Dr Adam Januszewski· @AdamJanuszewski · X·· 1 天前评分70
正文 · 原文
🇬🇧 Brilliant to see @tompowles1 AGAIN on the podium, leading the way in bladder cancer!
🚨 Phase III VOLGA:
✅ 49% ↓ EFS events/death
✅ 42% ↓ risk of death
✅ 45% pCR vs 10%
Fantastic UK & @NHSBartsHealth representation! 👏
#BladderCancer #VOLGA #ESMO2026
66 浏览 · 1 赞 · 1 转发 · 0 回复
会议摘要
LBA2按 Presidential Symposium I 对上
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.org来源：Dr Adam Januszewski · x.com